MAPT and Alzheimer disease: Among AD patients, CSF p-tau181 is the most thoroughly examined p-tau species, however recent data suggest that other epitopes demonstrate superior diagnostic utility (e.g., p-tau217) or earlier elevation in the disease process (e.g., p-tau231).